[Disorders of gastric emptying in diabetes. II. Treatment].
The application of novel investigative techniques has contributed to an increased understanding of the prevalence, pathophysiology and treatment of disordered gastric motility in diabetes. Gastrokinetic drugs have improved therapeutic options for symptomatic patients with gastroparesis considerably. Future approaches to modulate gastric and small intestinal sensory responses may lead to significant advances in treatment.
Czambor-Ksiazek
E
E
Oddiziału Chorób Wewnetrznych Szpitala Górniczego, Zabrzu.
Pokrzywnicki
W
W
Grzeszczak
W
W
Duda
G
G
D020117:Cisapride; D048909:Diabetes Complications; D004294:Domperidone / Q000627:therapeutic use; D015259:Dopamine Agents / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005746:Gastric Emptying / Q000187:drug effects*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D013272:Stomach Diseases / Q000188:drug therapy* / Q000209:etiology
D015259:Dopamine Agents; D010880:Piperidines; D004294:Domperidone; D004917:Erythromycin; D008787:Metoclopramide; D020117:Cisapride